protein subunit vaccine
subunit vaccine

The subunit vaccine is currently approved for use only in those 18 years of age and older.

Subunit vaccines are safe for immunocompromised patients because they cannot cause the disease.

They can also identify bacterial molecules that may act as subunit vaccines.

There has been much interest in the production of subunit vaccines against human and agricultural parasites since the early 1980s.

Subsequently, they developed additional subunit vaccines for use in pigs and cattle.

Biotechnology and genetic engineering techniques are used to produce subunit vaccines.

In one trial this is being used with a booster shot of a type of subunit vaccine.

Analysis of the relationship between immunogenicity and immunity for viral subunit vaccines.

Unsuccessful clinical trials have been conducted for glycoprotein subunit vaccines.

Subunit vaccines show antigens to the immune system, without introducing virus material.

This could lead to new subunit vaccines that would bypass current cold chain requirements for storage and distribution.

A characteristic example is the subunit vaccine against Hepatitis B virus.

Subunit vaccines are composed of small fragments of disease causing organisms.

Subunit vaccine is being used for plague immunization.

Just like the highly successful subunit vaccines, the recombinant-vector-produced antigen will be of little to no risk to the patient.

In a sense they are like subunit vaccines except that the antigen is produced within the cells of the individual to be immunised.

All are non-infectious subunit vaccines derived from genetically engineered yeast cells.

However, purified fusion-active complexes could be developed as an inactive subunit vaccine.

Early work with plant-based subunit vaccines used the readily transformed species tobacco, potato and tomato.

Merck is studying recombinant subunit vaccines expressed in Drosophila cells.

The highest humoral immune response was elicited by the subunit vaccine (rLipL32).

Key words: epitope, fusion protein, repeat sequence, subunit vaccine.

Subunit vaccines have excellent safety profiles and facilitate the preparation of a variety of combination products.

Comparison of vaccines Over 90% of adult horses showed a strong antibody response to a new subunit vaccine.

A subunit vaccine presents an antigen to the immune system without introducing viral particles, whole or otherwise.